These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9296330)

  • 21. [Iatrogenic Cushing's syndrome caused by an acute overdose of triamcinolone].
    Girre C; Vincens M; Gompel A; Fournier PE
    Therapie; 1987; 42(3):317-8. PubMed ID: 3660326
    [No Abstract]   [Full Text] [Related]  

  • 22. [Iatrogenic Cushing's syndrome caused by dexamethasome suppositories].
    Vilaseca J; Tor J; Libenson C; Guardia J
    Rev Clin Esp; 1980 Dec; 159(6):437-8. PubMed ID: 7221114
    [No Abstract]   [Full Text] [Related]  

  • 23. Cushing's syndrome from Klack's solution.
    Lankford HV
    Endocr Pract; 2000; 6(6):456-8. PubMed ID: 11155219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized phase II study comparing thalidomide with medroxyprogesterone acetate in patients with metastatic renal cell carcinoma.
    Lee CP; Patel PM; Selby PJ; Hancock BW; Mak I; Pyle L; James MG; Beirne DA; Steeds S; A'Hern R; Gore ME; Eisen T
    J Clin Oncol; 2006 Feb; 24(6):898-903. PubMed ID: 16484699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case of breast cancer with multiple metastases successfully treated by medroxyprogesterone acetate with intermittent intra-arterial infusion low-dose chemotherapy to hepatic metastasis].
    Kusama M; Kaise H; Nakayama S; Oota D; Shimizu H; Aoki T; Koyanagi Y
    Gan To Kagaku Ryoho; 2000 Dec; 27(14):2243-7. PubMed ID: 11142170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term survival of a patient with primarily chemo-resistant metastatic breast cancer treated with medroxyprogesterone acetate.
    Zaucha R; Sosińska-Mielcarek K; Jassem J
    Breast; 2004 Aug; 13(4):321-4. PubMed ID: 15325667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tamoxifen-induced radiation recall dermatitis.
    Kundranda MN; Daw HA
    Am J Clin Oncol; 2006 Dec; 29(6):637-8. PubMed ID: 17149005
    [No Abstract]   [Full Text] [Related]  

  • 28. [A case report of advanced breast cancer with remarkable response to chemoendocrine therapy (CTF + MPA)].
    Yokota T; Fujii T; Roppongi T; Kanno K; Ogata T
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):739-42. PubMed ID: 9571973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cushing's syndrome: new diagnostic developments and new treatments].
    te Raa GD; Slee PH
    Ned Tijdschr Geneeskd; 2007 Feb; 151(5):332; author reply 332. PubMed ID: 17326482
    [No Abstract]   [Full Text] [Related]  

  • 30. Adjuvant high-dose medroxyprogesterone acetate for early breast cancer: 13 years update in a multicentre randomized trial.
    Focan C; Beauduin M; Salamon E; de Greve J; de Wasch G; Lobelle JP; Majois F; Tagnon A; Tytgat J; van Belle S; Vandervellen R; Vindevoghel A;
    Br J Cancer; 2001 Jul; 85(1):1-8. PubMed ID: 11437394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cushing's syndrome induced by betamethasone nose drops. In rhinological disease betamethasone should be regarded as systemic corticosteroid.
    Homer JJ; Gazis TG
    BMJ; 1999 May; 318(7194):1355. PubMed ID: 10323840
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cushing's syndrome induced by local corticotherapy in an infant].
    Ronayette D; Hennequin D; Bouquier JJ; Bonnetblanc JM
    Nouv Presse Med; 1978 Feb; 7(5):368. PubMed ID: 634774
    [No Abstract]   [Full Text] [Related]  

  • 33. Cushing's syndrome induced by betamethasone nose drops. Learning difficulties may complicate the issue.
    Scorrer T; Barton J
    BMJ; 1999 May; 318(7194):1356. PubMed ID: 10383214
    [No Abstract]   [Full Text] [Related]  

  • 34. Cushing's syndrome induced by betamethasone nose drops. Children taking intranasal corticosteroids should be monitored for growth retardation.
    Malozowski S; Purucker M; Worobec A
    BMJ; 1999 May; 318(7194):1355. PubMed ID: 10383213
    [No Abstract]   [Full Text] [Related]  

  • 35. Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer.
    Palmieri D; Halverson DO; Ouatas T; Horak CE; Salerno M; Johnson J; Figg WD; Hollingshead M; Hursting S; Berrigan D; Steinberg SM; Merino MJ; Steeg PS
    J Natl Cancer Inst; 2005 May; 97(9):632-42. PubMed ID: 15870434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of medications and hormones used in pediatric endocrinology: adrenal.
    Frank GR; Speiser PW; Griffin KJ; Stratakis CA
    Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():134-45. PubMed ID: 16456492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cushing's syndrome caused by topical steroid therapy for psoriasis.
    Abma EM; Blanken R; De Heide LJ
    Neth J Med; 2002 Apr; 60(3):148-50. PubMed ID: 12164372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dexamethasone and medroxyprogesterone acetate elevate Nm23-H1 metastasis suppressor gene expression in metastatic human breast carcinoma cells: new uses for old compounds.
    Ouatas T; Halverson D; Steeg PS
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3763-72. PubMed ID: 14506169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cushing's syndrome mimicking lipodystrophy syndrome in a patient with AIDS.
    Bates SM; Page KB; Nakielny RA; Talbot MD
    Int J STD AIDS; 2002 Sep; 13(9):648-9. PubMed ID: 12243135
    [No Abstract]   [Full Text] [Related]  

  • 40. [Transitory Cushing's syndrome?].
    Ebel KD
    Ann Radiol (Paris); 1968; 11(5):365-6. PubMed ID: 5678779
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.